Cargando…

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation

AIMS: The CHA(2)DS(2)-VASc score is fundamental to stroke risk assessment in atrial fibrillation. However, stroke-related risk factors can be modified later in life. This study aimed to assess the association of changes in CHA(2)DS(2)-VASc score over time (Delta CHA(2)DS(2)-VASc score) with the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsiartas, Eirinaios, Samaras, Athanasios, Papazoglou, Andreas S., Kartas, Anastasios, Moysidis, Dimitrios V., Gemousakakis, Eleftherios, Kamzolas, Odysseas, Bekiaridou, Alexandra, Doundoulakis, Ioannis, Tzikas, Apostolos, Giannakoulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465382/
https://www.ncbi.nlm.nih.gov/pubmed/37311823
http://dx.doi.org/10.1007/s00380-023-02278-1
_version_ 1785098661527552000
author Tsiartas, Eirinaios
Samaras, Athanasios
Papazoglou, Andreas S.
Kartas, Anastasios
Moysidis, Dimitrios V.
Gemousakakis, Eleftherios
Kamzolas, Odysseas
Bekiaridou, Alexandra
Doundoulakis, Ioannis
Tzikas, Apostolos
Giannakoulas, George
author_facet Tsiartas, Eirinaios
Samaras, Athanasios
Papazoglou, Andreas S.
Kartas, Anastasios
Moysidis, Dimitrios V.
Gemousakakis, Eleftherios
Kamzolas, Odysseas
Bekiaridou, Alexandra
Doundoulakis, Ioannis
Tzikas, Apostolos
Giannakoulas, George
author_sort Tsiartas, Eirinaios
collection PubMed
description AIMS: The CHA(2)DS(2)-VASc score is fundamental to stroke risk assessment in atrial fibrillation. However, stroke-related risk factors can be modified later in life. This study aimed to assess the association of changes in CHA(2)DS(2)-VASc score over time (Delta CHA(2)DS(2)-VASc score) with the risk of ischemic stroke. MATERIALS AND METHODS: This is an observational analysis of 1127 atrial fibrillation patients previously enrolled in the MISOAC-AF trial. After a median 2.6-year follow-up period, baseline and follow-up CHA(2)DS(2)-VASc scores were used to extract the Delta CHA(2)DS(2)-VASc score. The stroke predicting accuracies of the baseline, follow-up, and Delta CHA(2)DS(2)-VASc scores were assessed through regression analyses. RESULTS: The mean baseline, follow-up, and Delta CHA(2)DS(2)-VASc scores were 4.2, 4.8, and 0.6 respectively. Ischemic stroke occurred in 54 (4.4%) patients, of which 83.3% had a Delta CHA(2)DS(2)-VASc score ≥1, contrary to 40.1% of the stroke-free group. The stroke risk per 1-point increase of the CHA(2)DS(2)-VASc score was not significantly associated with the baseline score (aHR=1.14; 95%CI: 0.93-1.41; p=0.201), whereas a significant association was observed with the follow-up (aHR=2.58; 95% CI: 2.07-3.21; p<0.001) and Delta (aHR=4.56; 95%CI: 3.50-5.94; p<0.001) scores. C-index assessment indicated that follow-up and Delta CHA(2)DS(2)-VASc scores were more potent predictors of ischemic stroke compared to baseline. CONCLUSION: In atrial fibrillation patients, changes in CHA(2)DS(2)-VASc score over time were associated with the incidence of stroke. The improved predictability of follow-up and Delta CHA(2)DS(2)-VASc scores indicates that stroke risk is not a static parameter. TRIAL REGISTRATION: This is an observational, post-hoc analysis of the MISOAC-AF randomized controlled trial, registered on ClinicalTrials.gov (identifier: NCT02941978; registered: October 21, 2016). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-023-02278-1.
format Online
Article
Text
id pubmed-10465382
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-104653822023-08-31 Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation Tsiartas, Eirinaios Samaras, Athanasios Papazoglou, Andreas S. Kartas, Anastasios Moysidis, Dimitrios V. Gemousakakis, Eleftherios Kamzolas, Odysseas Bekiaridou, Alexandra Doundoulakis, Ioannis Tzikas, Apostolos Giannakoulas, George Heart Vessels Original Article AIMS: The CHA(2)DS(2)-VASc score is fundamental to stroke risk assessment in atrial fibrillation. However, stroke-related risk factors can be modified later in life. This study aimed to assess the association of changes in CHA(2)DS(2)-VASc score over time (Delta CHA(2)DS(2)-VASc score) with the risk of ischemic stroke. MATERIALS AND METHODS: This is an observational analysis of 1127 atrial fibrillation patients previously enrolled in the MISOAC-AF trial. After a median 2.6-year follow-up period, baseline and follow-up CHA(2)DS(2)-VASc scores were used to extract the Delta CHA(2)DS(2)-VASc score. The stroke predicting accuracies of the baseline, follow-up, and Delta CHA(2)DS(2)-VASc scores were assessed through regression analyses. RESULTS: The mean baseline, follow-up, and Delta CHA(2)DS(2)-VASc scores were 4.2, 4.8, and 0.6 respectively. Ischemic stroke occurred in 54 (4.4%) patients, of which 83.3% had a Delta CHA(2)DS(2)-VASc score ≥1, contrary to 40.1% of the stroke-free group. The stroke risk per 1-point increase of the CHA(2)DS(2)-VASc score was not significantly associated with the baseline score (aHR=1.14; 95%CI: 0.93-1.41; p=0.201), whereas a significant association was observed with the follow-up (aHR=2.58; 95% CI: 2.07-3.21; p<0.001) and Delta (aHR=4.56; 95%CI: 3.50-5.94; p<0.001) scores. C-index assessment indicated that follow-up and Delta CHA(2)DS(2)-VASc scores were more potent predictors of ischemic stroke compared to baseline. CONCLUSION: In atrial fibrillation patients, changes in CHA(2)DS(2)-VASc score over time were associated with the incidence of stroke. The improved predictability of follow-up and Delta CHA(2)DS(2)-VASc scores indicates that stroke risk is not a static parameter. TRIAL REGISTRATION: This is an observational, post-hoc analysis of the MISOAC-AF randomized controlled trial, registered on ClinicalTrials.gov (identifier: NCT02941978; registered: October 21, 2016). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-023-02278-1. Springer Japan 2023-06-13 2023 /pmc/articles/PMC10465382/ /pubmed/37311823 http://dx.doi.org/10.1007/s00380-023-02278-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Tsiartas, Eirinaios
Samaras, Athanasios
Papazoglou, Andreas S.
Kartas, Anastasios
Moysidis, Dimitrios V.
Gemousakakis, Eleftherios
Kamzolas, Odysseas
Bekiaridou, Alexandra
Doundoulakis, Ioannis
Tzikas, Apostolos
Giannakoulas, George
Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
title Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
title_full Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
title_fullStr Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
title_full_unstemmed Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
title_short Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
title_sort changes in cha(2)ds(2)-vasc score and risk of ischemic stroke among patients with atrial fibrillation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465382/
https://www.ncbi.nlm.nih.gov/pubmed/37311823
http://dx.doi.org/10.1007/s00380-023-02278-1
work_keys_str_mv AT tsiartaseirinaios changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT samarasathanasios changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT papazoglouandreass changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT kartasanastasios changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT moysidisdimitriosv changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT gemousakakiseleftherios changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT kamzolasodysseas changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT bekiaridoualexandra changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT doundoulakisioannis changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT tzikasapostolos changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation
AT giannakoulasgeorge changesincha2ds2vascscoreandriskofischemicstrokeamongpatientswithatrialfibrillation